353 related articles for article (PubMed ID: 14550648)
1. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
[TBL] [Abstract][Full Text] [Related]
2. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
[TBL] [Abstract][Full Text] [Related]
3. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
[TBL] [Abstract][Full Text] [Related]
4. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
Persson S; Torpdahl M; Olsen KE
Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
6. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
[TBL] [Abstract][Full Text] [Related]
7. Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile.
Mathis JN; Pilkinton L; McMillin DE
Curr Microbiol; 1999 Jun; 38(6):324-8. PubMed ID: 10341072
[TBL] [Abstract][Full Text] [Related]
8. Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding.
Artiushin S; Timoney JF; Fettinger M; Fallon L; Rathgeber R
Equine Vet J; 2013 Jul; 45(4):476-80. PubMed ID: 23206274
[TBL] [Abstract][Full Text] [Related]
9. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
Zhang Y; Hamza T; Gao S; Feng H
Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.
Anjuwon-Foster BR; Maldonado-Vazquez N; Tamayo R
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735765
[No Abstract] [Full Text] [Related]
12. Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.
Maynard-Smith M; Ahern H; McGlashan J; Nugent P; Ling R; Denton H; Coxon R; Landon J; Roberts A; Shone C
Vaccine; 2014 Feb; 32(6):700-5. PubMed ID: 24342251
[TBL] [Abstract][Full Text] [Related]
13. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
[TBL] [Abstract][Full Text] [Related]
14. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Shin BM; Lee EJ; Kuak EY; Yoo SJ
Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
[TBL] [Abstract][Full Text] [Related]
15. Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.
Sturino JM; Pokusaeva K; Carpenter R
Antimicrob Agents Chemother; 2015 Dec; 59(12):7178-83. PubMed ID: 26149988
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.
Zhang BZ; Cai J; Yu B; Hua Y; Lau CC; Kao RY; Sze KH; Yuen KY; Huang JD
BMC Infect Dis; 2016 Oct; 16(1):596. PubMed ID: 27770789
[TBL] [Abstract][Full Text] [Related]
17. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
18. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
20. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
